Multiple SA institutions collaborate on cancer research involving TB vaccine
The Texas Biomedical Research Institute, Southwest Research Institute and UT Health San Antonio are teaming on a nonsurgical treatment for bladder cancer.
Texas Biomed professor Jordi Torrelles and UT Health San Antonio’s Dr. Robert Svatek will be principle investigators on the new project. They will study the use of a modified Mycobacterium bovis Bacillus Calmette et Guérin, or BCG, vaccine as a treatment for a type of cancer that is expected t o affect more than 2% of the world’s population… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 30, 2019 Category: Pharmaceuticals Authors: W. Scott Bailey Source Type: news
New TB Vaccine Could Save Millions of Lives, Study Suggests
There are 10 million new cases each year of tuberculosis, now the leading infectious cause of death worldwide. Even a partly effective vaccine could help turn the tide. (Source: NYT Health)
Source: NYT Health - October 29, 2019 Category: Consumer Health News Authors: Donald G. McNeil Jr. Tags: Tuberculosis Vaccination and Immunization Tests (Medical) Antibiotics New England Journal of Medicine World Health Organization Gavi, the Vaccine Alliance Berkley, Seth Kenya South Africa Zambia Source Type: news
'Game changing' tuberculosis vaccine a step closer
TB is one of the top 10 causes of death worldwide and kills 1.5 million people each year. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - October 29, 2019 Category: Consumer Health News Source Type: news
GSK's tuberculosis vaccine shows promising results
The new vaccine, known as M72/AS01E, was tested at 11 sites in Kenya, South Africa and Zambia in adults whose blood tests showed they had latent TB. The study revealed that the vaccine could cut the number of people developing TB by half. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 28, 2019 Category: Pharmaceuticals Source Type: news
Childhood TB Shot May Offer Lung Cancer Protection
A tuberculosis vaccine commonly used in other parts of the world might reduce a person's risk of developing lung cancer if given early in childhood, a six-decade-long study reports. (Source: WebMD Health)
Source: WebMD Health - October 1, 2019 Category: Consumer Health News Source Type: news
Childhood TB Shot May Offer Long-Term Protection from Lung Cancer
TUESDAY, Oct. 1, 2019 -- A tuberculosis vaccine commonly used in other parts of the world might reduce a person ' s risk of developing lung cancer if given early in childhood, a six-decade-long study reports.
The Bacille Calmette-Guerin (BCG) vaccine... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 1, 2019 Category: General Medicine Source Type: news
NIH awards contracts to advance tuberculosis immunology research
Research will help advance TB vaccine development. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - September 26, 2019 Category: American Health Source Type: news
QuickStats: Age-Adjusted Death Rates from Diabetes Mellitus as Underlying or Contributing Cause Among Adults Aged ≥65 Years, by Race/Ethnicity --- National Vital Statistics System, United States, 2004--2017
During 2004-2017, the death rate from diabetes mellitus as underlying or contributing cause among adults aged ≥65 years decreased in the United States. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 20, 2019 Category: American Health Tags: Diabetes MMWR Morbidity & Mortality Weekly Report Older Adult's Health Tuberculosis (TB) Tuberculosis Vaccine (BCG) Source Type: news
Notes from the Field: Meningeal and Pulmonary Tuberculosis on a Commercial Fishing Vessel --- Hawaii, 2017
In December 2016, U.S. Customs and Border Protection notified the CDC Honolulu Quarantine Station of a crewman on a commercial fishing vessel who was hospitalized with suspected tuberculosis. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 20, 2019 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Tuberculosis (TB) Tuberculosis Vaccine (BCG) Source Type: news
Kenya: Baby's Hand, Foot Amputated After BCG Vaccination
[Nation] Mr Peter Gitonga and his wife Leah Waithira are angry and disappointed parents. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 11, 2019 Category: African Health Source Type: news
New tools and strategies for tuberculosis diagnosis, care, and elimination: A PLOS Medicine special
(PLOS) This week, publication of a special issue on tuberculosis (TB) begins in PLOS Medicine, advised by guest editors Richard Chaisson of Johns Hopkins University, Claudia Denkinger of the University of Heidelberg, and Mark Hatherill of the South African Tuberculosis Vaccine Institute. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2019 Category: International Medicine & Public Health Source Type: news
IDRI partners with Afrigen Biologics and Biovac to produce tuberculosis vaccine
(Infectious Disease Research Institute) In an effort to produce vaccines where they are needed most, IDRI (Infectious Disease Research Institute) is collaborating with the Cape Town, South Africa, based biotechnology startup company Afrigen Biologics, founded by the Industrial Development Corporation of South Africa and IDRI, and its production partner the Biovac Institute (Biovac), a vaccine manufacturer also located in Cape Town, to produce a vaccine for tuberculosis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 20, 2019 Category: Infectious Diseases Source Type: news
Clinical trial starts for temperature-stable tuberculosis vaccine
Researchers have started conducting trials with an experimental tuberculosis vaccine candidate that can survive without refrigeration, the National Institutes of Health said. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 23, 2019 Category: Consumer Health News Source Type: news
Temperature-stable experimental tuberculosis vaccine enters clinical testing
Tuberculosis remains the leading infectious cause of death worldwide. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - January 23, 2019 Category: American Health Source Type: news
Temperature-stable experimental tuberculosis vaccine enters clinical testing
(NIH/National Institute of Allergy and Infectious Diseases) A Phase 1 human clinical trial is testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis (TB) vaccine. The trial is being conducted at the Saint Louis University School of Medicine Center for Vaccine Development and will enroll healthy adult volunteers. The experimental vaccine, called ID93, was developed by scientists at the Infectious Disease Research Institute in Seattle. The National Institute of Allergy and Infectious Diseases is supporting the trial through a contract to IDRI. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 23, 2019 Category: Infectious Diseases Source Type: news
